Promising reduction of de novo resistance to endocrine therapies in breast cancer by small molecules from natural origin: a structural approach
Purpose: To investigate the pharmacokinetic properties and inhibitory binding interaction between naturally occurring phytochemicals and a mutated human estrogen receptor (hERα) using an in silico approach. Methods: Naturally occurring small molecules, viz, myricetin, catechin, pinobanksin, pinocemb...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
University of Benin
2024
|
| Online Access: | http://psasir.upm.edu.my/id/eprint/113536/1/113536.pdf |
| _version_ | 1817927948647268352 |
|---|---|
| author | Etti, Imaobong C. Kadir, Arifah A. Uweh, Esther J. Okuku, Cecilia Abdullah, Rasedee |
| author_facet | Etti, Imaobong C. Kadir, Arifah A. Uweh, Esther J. Okuku, Cecilia Abdullah, Rasedee |
| author_sort | Etti, Imaobong C. |
| collection | UPM |
| description | Purpose: To investigate the pharmacokinetic properties and inhibitory binding interaction between naturally occurring phytochemicals and a mutated human estrogen receptor (hERα) using an in silico approach. Methods: Naturally occurring small molecules, viz, myricetin, catechin, pinobanksin, pinocembrin, gelagin and pinostrobin, were investigated for their drug-likeness and pharmacokinetic properties. After that, molecular docking was used to study their binding affinities to Y537S (Tyr537Ser: a mutated estrogen receptor alpha, prominent in metastatic breast cancers). The structure of the ligand-binding domain (LBD) of human estrogen receptor was retrieved from Protein Data Bank while the structures of the studied compounds were collected from PubChem database. Using Schrodinger docking studio, the binding interactions of each phytochemical were investigated with the mutated estrogen receptor. Results: All studied compounds were observed to be drug-like with good physicochemical properties. Myricetin, catechin, pinobanksin, pinocembrin, gelagin and pinostrobin showed good solubilities in human oral absorption and good intestinal permeability, which are the rate-limiting barriers for oral drug absorption. The distribution of the studied ligands and their plasma protein binding parameters were better than those of tamoxifen, which has previously been reported with high potential binding to albumin. None of the studied compounds showed central nervous system toxicity. The binding studies revealed good inhibition of the LBD of Y537S-hERα. This is a targeted approach to selectively inhibit this receptor which has been reported to confer ligand-independent functions to ERα. This inhibition prevents downstream signaling and metastasis, rendering breast cancer cells harboring such mutations susceptible to apoptosis upon treatment with endocrine therapies. Conclusion: The compounds have the potential to mitigate de novo resistance in breast cancer cells harboring mutated estrogen receptors and should be further investigated as they are promising for oral delivery. |
| first_indexed | 2024-12-09T02:26:33Z |
| format | Article |
| id | upm.eprints-113536 |
| institution | Universiti Putra Malaysia |
| language | English |
| last_indexed | 2024-12-09T02:26:33Z |
| publishDate | 2024 |
| publisher | University of Benin |
| record_format | dspace |
| spelling | upm.eprints-1135362024-11-26T03:44:41Z http://psasir.upm.edu.my/id/eprint/113536/ Promising reduction of de novo resistance to endocrine therapies in breast cancer by small molecules from natural origin: a structural approach Etti, Imaobong C. Kadir, Arifah A. Uweh, Esther J. Okuku, Cecilia Abdullah, Rasedee Purpose: To investigate the pharmacokinetic properties and inhibitory binding interaction between naturally occurring phytochemicals and a mutated human estrogen receptor (hERα) using an in silico approach. Methods: Naturally occurring small molecules, viz, myricetin, catechin, pinobanksin, pinocembrin, gelagin and pinostrobin, were investigated for their drug-likeness and pharmacokinetic properties. After that, molecular docking was used to study their binding affinities to Y537S (Tyr537Ser: a mutated estrogen receptor alpha, prominent in metastatic breast cancers). The structure of the ligand-binding domain (LBD) of human estrogen receptor was retrieved from Protein Data Bank while the structures of the studied compounds were collected from PubChem database. Using Schrodinger docking studio, the binding interactions of each phytochemical were investigated with the mutated estrogen receptor. Results: All studied compounds were observed to be drug-like with good physicochemical properties. Myricetin, catechin, pinobanksin, pinocembrin, gelagin and pinostrobin showed good solubilities in human oral absorption and good intestinal permeability, which are the rate-limiting barriers for oral drug absorption. The distribution of the studied ligands and their plasma protein binding parameters were better than those of tamoxifen, which has previously been reported with high potential binding to albumin. None of the studied compounds showed central nervous system toxicity. The binding studies revealed good inhibition of the LBD of Y537S-hERα. This is a targeted approach to selectively inhibit this receptor which has been reported to confer ligand-independent functions to ERα. This inhibition prevents downstream signaling and metastasis, rendering breast cancer cells harboring such mutations susceptible to apoptosis upon treatment with endocrine therapies. Conclusion: The compounds have the potential to mitigate de novo resistance in breast cancer cells harboring mutated estrogen receptors and should be further investigated as they are promising for oral delivery. University of Benin 2024 Article PeerReviewed text en cc_by_4 http://psasir.upm.edu.my/id/eprint/113536/1/113536.pdf Etti, Imaobong C. and Kadir, Arifah A. and Uweh, Esther J. and Okuku, Cecilia and Abdullah, Rasedee (2024) Promising reduction of de novo resistance to endocrine therapies in breast cancer by small molecules from natural origin: a structural approach. Tropical Journal of Pharmaceutical Research, 23 (6). pp. 923-932. ISSN 1596-5996; eISSN: 1596-9827 https://www.tjpr.org/home/abstract.php?id=4258 10.4314/tjpr.v23i6.2 |
| spellingShingle | Etti, Imaobong C. Kadir, Arifah A. Uweh, Esther J. Okuku, Cecilia Abdullah, Rasedee Promising reduction of de novo resistance to endocrine therapies in breast cancer by small molecules from natural origin: a structural approach |
| title | Promising reduction of de novo resistance to endocrine therapies in breast cancer by small molecules from natural origin: a structural approach |
| title_full | Promising reduction of de novo resistance to endocrine therapies in breast cancer by small molecules from natural origin: a structural approach |
| title_fullStr | Promising reduction of de novo resistance to endocrine therapies in breast cancer by small molecules from natural origin: a structural approach |
| title_full_unstemmed | Promising reduction of de novo resistance to endocrine therapies in breast cancer by small molecules from natural origin: a structural approach |
| title_short | Promising reduction of de novo resistance to endocrine therapies in breast cancer by small molecules from natural origin: a structural approach |
| title_sort | promising reduction of de novo resistance to endocrine therapies in breast cancer by small molecules from natural origin a structural approach |
| url | http://psasir.upm.edu.my/id/eprint/113536/1/113536.pdf |
| work_keys_str_mv | AT ettiimaobongc promisingreductionofdenovoresistancetoendocrinetherapiesinbreastcancerbysmallmoleculesfromnaturaloriginastructuralapproach AT kadirarifaha promisingreductionofdenovoresistancetoendocrinetherapiesinbreastcancerbysmallmoleculesfromnaturaloriginastructuralapproach AT uwehestherj promisingreductionofdenovoresistancetoendocrinetherapiesinbreastcancerbysmallmoleculesfromnaturaloriginastructuralapproach AT okukucecilia promisingreductionofdenovoresistancetoendocrinetherapiesinbreastcancerbysmallmoleculesfromnaturaloriginastructuralapproach AT abdullahrasedee promisingreductionofdenovoresistancetoendocrinetherapiesinbreastcancerbysmallmoleculesfromnaturaloriginastructuralapproach |